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Abstract
Background: Clean birth practices can prevent sepsis, one of the leading causes of both maternal and newborn
mortality. Evidence suggests that clean birth kits (CBKs), as part of package that includes education, are associated
with a reduction in newborn mortality, omphalitis, and puerperal sepsis. However, questions remain about how
best to approach the introduction of CBKs in country. We set out to develop a practical decision support tool for
programme managers of public health systems who are considering the potential role of CBKs in their strategy for
care at birth.
Methods: Development and testing of the decision support tool was a three-stage process involving an
international expert group and country level testing. Stage 1, the development of the tool was undertaken by the
Birth Kit Working Group and involved a review of the evidence, a consensus meeting, drafting of the proposed tool
and expert review. In Stage 2 the tool was tested with users through interviews (9) and a focus group, with federal
and provincial level decision makers in Pakistan. In Stage 3 the findings from the country level testing were
reviewed by the expert group.
Results: The decision support tool comprised three separate algorithms to guide the policy maker or programme
manager through the specific steps required in making the country level decision about whether to use CBKs. The
algorithms were supported by a series of questions (that could be administered by interview, focus group or
questionnaire) to help the decision maker identify the information needed. The country level testing revealed that
the decision support tool was easy to follow and helpful in making decisions about the potential role of CBKs.
Minor modifications were made and the final algorithms are presented.
Conclusion: Testing of the tool with users in Pakistan suggests that the tool facilitates discussion and aids decision
making. However, testing in other countries is needed to determine whether these results can be replicated and to
identify how the tool can be adapted to meet country specific needs.
Keywords: Clean birth practices, Birth kits, Decision support tool
Background
Sepsis is one of the leading causes of both maternal [1]
and newborn mortality [2,3]. Ensuring that birth prac-
tices are clean is estimated to reduce neonatal mortality
due to tetanus by 30% in home births and 38% in facility
births [4]. Clean birth practices, combined with monitor-
ing and active third stage management, may prevent up
to 23% of maternal deaths in low income countries [5].
Achieving a clean birth requires the application of skills
by the care provider and access to essential supplies,
such as soap. For several decades clean birth kits (CBKs)
have been recommended as a means of ensuring those
supplies. The World Health Organization (WHO) has
supported CBK use as a means by which to explicitly
“strengthen standards of cleanliness” in home deliveries
[6] and within health facilities that lack the capacity to
sterilise equipment [7]. A recent systematic review found
that CBKs, as part of package that included education,
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were associated with reduced newborn mortality,
omphalitis, and puerperal sepsis [8]. It also highlighted
the heterogeneity in terms of the contents of CBKs and
the methods by which the CBK was distributed; raising
questions about how best to approach the introduction
of CBKs in country. We set out to develop a practical
tool, based on the available data, for use at national and
sub-national level. The tool was aimed at policy makers
and programme managers; specifically those decision
makers planning the overall strategy for care at birth,
which would include encouraging women to give birth
in facilities and improving supply and demand of com-
modities at the lowest level of community and facility
health care.
Pakistan was chosen for the test of the decision sup-
port tool as it is representative of a number of countries
making progress in maternal mortality reduction, but
unlikely to meet the Millennium Development Goal
(MDG) target set for 2015. Pakistan has an estimated
maternal mortality of 260 per 100,000 live births [9]; an
estimate that reflects a 48% reduction in maternal mor-
tality since 1990 [9], but indicates that accelerated pro-
gress is needed to achieve the target set for 2015. The
maternal mortality ratio (MMR) is significantly higher in
rural areas, largely as a consequence of inequities in
health service utilisation [10]; recent figures show that
only 30% of births in rural areas were attended by a
skilled care provider compared with 60% in urban areas
[11]. In Pakistan, sepsis is the second leading cause of
both maternal (13.7%) and neonatal mortality (20%)
[10]. A recent survey suggests that failures in hygienic
practices may contribute significantly to the problem
[12]. Hassan et al. found that unhygienic practices were
common among traditional birth attendants (TBAs), but
were also evident among skilled birth attendants work-
ing in Sindh province [12]. A lack of resources and edu-
cational requirements has also been implicated in the
high neonatal mortality rates [13,14]. CBKs have been
recommended as a method of overcoming the challenges
of accessing essential supplies in Pakistan, and along
with education, could be a valuable tool in promoting
safe childbirth [12].
This paper reports the development and testing of the
decision support tool; a three-stage process involving
an international expert group and country level testing
(Figure 1). The aim was to produce a practical tool for
use by policy makers and programme managers who
are considering the potential role of CBKs in their
strategy for care at birth.
Methods
Tool development
Development of the decision support tool was under-
taken by the Birth Kit Working Group (BKWG) (Table 1)
and involved a review of the evidence, a consensus meet-
ing, drafting of the proposed tool and expert review.
Members of the BKWG undertook two substantial litera-
ture reviews to examine the issues surrounding clean birth
practices and the effectiveness of CBKs [4,8]. The inter-
national, multidisciplinary BKWG (comprising clinicians,
researchers, policy makers and programme managers) met
on two occasions to review the evidence, discuss the issues
and draft an outline for the decision support tool. Tool
development was conducted by a smaller working group,
and the tool was then circulated to experts for peer
review (Table 1) and amendments made.
The tool comprised three separate algorithms to guide
the policy maker or programme manager through the
specific steps required in making the country level deci-
sion about whether to use CBKs. In order to help the
user identify the required information, each algorithm
was followed by a series of questions that could be admi-
nistered by interview, focus group or questionnaire.
 Algorithm 1 - establishing whether there is a need
for clean birth kits (Figure 2) - Evidence from the
two systematic reviews [4,8] demonstrated a
significant role for CBKs in promoting clean birth
practices, thus algorithm 1 focuses on the
prevalence of clean birth practices and whether
there is a need to consider using CBKs. This
includes identifying whether there are sub-
populations with low rates of clean birth practices.
 Algorithm 2 - identifying how clean birth kits will be
distributed (Figure 3) - Having identified a role for
CBKs in improving clean birth practices, the
decision maker needs to decide how best to
distribute CBKs in country. Algorithm 2 guides the
decision maker through the possible routes of
distribution that were identified from the review of
literature [15]. The aim is to identify a route that is
appropriate to the country specific context
(e.g. taking into account considerations such as
geography and infrastructure).
 Algorithm 3 - identifying whether there is a need for
additional components (Figure 4) – Here the
decision maker is asked to look at whether non-
sepsis related causes of mortality and morbidity
could be addressed by adding relevant components
to the CBK. An example of such a component is
misoprostol for the prevention of postpartum
haemorrhage. The intention is for the decision
maker to identify components that address country
specific needs.
If the decision is supportive of a potential role for
CBKs, a further step would be required to explore prac-
tical considerations such as procurement, cost and issues
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relating to utilisation (e.g. training). This would also in-
clude the potential for evaluation of the programme.
Details of this step are not included in the tool, as they
would need to be country specific and take into account
existing protocols regarding the health system and sup-
ply chains. The final versions of the algorithms appear in
Figures 2,3,4. The full decision support tool is available
on the Immpact web site [16].
Country level test of the tool
Qualitative methods were used to conduct the test with
policy makers and programme managers in Pakistan
Table 1 Group members
Members of the Birth Kit
Working Group:
Priya Agrawal (Harvard School of Public Health), Haris Ahmed (Pathfinder), Bilal Avan (IDEAS, LSHTM), Ann Blanc
(MHTF), Hannah Blencowe (LSHTM), Thomas Burke (Harvard Medical School), Oona Campbell (LSHTM), Mickey
Chopra (UNICEF), Patricia Coffey (PATH), Anthony Costello (ICH/UCL), Simon Cousens (LSHTM), Jo Cox (MM
Campaign), Susan Crane (ICH/UCL), Luc de Bernis (UNFPA), Luis Andres de Francisco Serpa (WHO), France Donnay
(Gates Foundation), Mark Dybul (Georgetown University), Melody Eckardt (Harvard Medical School), Helga Fogstad
(Norad), Lynn Freedman (AMDD), Wendy Graham (Immpact), Homaira Hanif (JHU), Elizabeth Hoff (Millenium
Foundation), Vanora Hundley (Bournemouth University), Jessica Hulse (SNL), Lily Kak (USAID), Asma Khalid (MSI),
Louise Kleberg (Millenium Foundation), Joy Lawn (SNL), Helena Lindborg (DFID), Elizabeth Leahy Madsen (MHTF),
Nahed Matta (USAID), Zoe Matthews (University of Southampton); Peter McDermott (CIFF), Claudia Morrissey (SNL),
Luke Mullany (JHU), Anne Pfitzer (SNL), Melanie Ridge (ICH/UCL), Craig Rubens (GAPPS), Lale Say (WHO), Unni
Silkoset (Norad), Ann Starrs (FCI), Catherine Taylor (PATH), Steve Wall (SNL), Eva Weissman (Futures Institute), and
Peter Winch (JHU).
Members of the tool
development group:
Haris Ahmed (Pathfinder), Bilal Avan (IDEAS, LSHTM), Hannah Blencowe (LSHTM), Wendy Graham (Immpact), Vanora
Hundley (Bournemouth University), and Joy Lawn (SNL).
Expert reviewers in stage 1: Ann Blanc (MHTF), Melody Eckardt (Harvard Medical School), Asma Khalid (MSI), Claudia Morrissey (SNL), and Steve
Wall (SNL).
Stage 1: Development
Systematic reviews of the 
evidence 
Consensus meeting and tool 
development
Expert review of the decision 
support tool (draft)
Stage 2: In country pre-test
Decision Support tool
Semi-structured interviews 
with 6 representatives from 
the Ministry of Health and 
the Department of Health 
(federal level)
Semi-structured interviews 
with 3 representatives 
(provincial level).
Focus group discussion 
with 6 district level 
managers
Evidence synthesised and 
recommendations 
incorporated
Stage 3: Expert review
Expert review of the decision 
support tool (final)
Figure 1 Development and testing of the decision support tool.
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[17,18]. Purposive sampling ensured that both federal
and provincial level decision makers were included in
the study [17]. Semi structured interviews were con-
ducted with six representatives from the Federal Ministry
of Health in Islamabad and with three representatives
from the Provincial Department of Health Punjab in
Lahore. The opinion of district level management was
sought through a focus group discussion (FGD) conducted
in the Chakwal district (six participants). The process
involved participants working through the decision tool in
the presence of the interviewer and reflecting on the ease
of completion and the value of the tool. Ethical approval
was sought but, because the interviews involved health
service officials and not patients, we were advised instead
to seek formal permissions from the health departments
involved and these were obtained. All participants gave
informed consent prior to the interviews.
The interview schedule was drafted by the field coord-
inator (HA) under the guidance of the BKWG members
and followed the format of the decision support tool.
The schedule allowed the participants to work through
the decision support tool in the presence of the inter-
viewer, and to identify areas that needed clarification.
The interview schedule was piloted [19] with two parti-
cipants in private practice.
Focus group interviews followed a similar format, with
the algorithms being presented to the participants to
stimulate discussion. However, the discussion was more
open with the facilitator using the questions within the
decision support tool as prompts if required.
Figure 2 Algorithm 1 – establishing whether there is a need for clean birth kits.
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Two interviewers were identified by the field coordin-
ator based on their local knowledge and experience in
conducting interviews and focus group discussions. The
interviewers worked together as a team, and this enabled
the interviews to be recorded by hand since participants
preferred not to be tape recorded. All participants were
informed about the nature and purpose of the study
prior to the interview. They were assured that their
responses would remain confidential, and that they
would not be identifiable in study reports. The inter-
views were recorded verbatim in Urdu and English, and
then translated into English for analysis. Responses were
categorised according to the algorithms to which they
related and the specific steps within those algorithms
[20]. Quotes were selected to illustrate the themes from
participants’ responses. For the purposes of reporting,
interview quotes are labelled as P1-P9 for interview par-
ticipants and FG1-FG6 for focus group participants.
The process of developing the decision support tool,
testing and amending it was detailed as part of the min-
utes of the BKWG and served as an audit trail for the
work.
Results
Participants
All nine interviewees held positions as policy makers or
programme managers within the Department or Minis-
try of Health (six in the Federal Ministry of Health in
Islamabad and three in the Provincial Department of
Health Punjab in Lahore). Four had been in post for
more than two years, three for one year and two for less
than a year. Seven of the participants were male and two
were female. It is not possible to give details of their
position in order to maintain confidentiality. The six
focus group participants all held positions within district
level management in the Chakwal district. Five were
male and one was female. All had responsibility for pub-
lic health.
Tool as a whole
The country level testing revealed that the decision sup-
port tool was easy to follow and helpful in making deci-
sions about the potential role of CBKs in their country’s
strategy for care at birth.
Figure 3 Algorithm 2 – identifying how clean birth kits will be distributed.
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“very helpful, self-explanatory and thought provoking.”
(P5)
“very helpful. It gives you food for thought.” (P2).
Some participants reported that the tool was particu-
larly helpful in initiating discussion: “It made the concept
much clearer. The thoughts are there – clarity to bring it
on track.” (P4)
Algorithm 1
The main challenge for participants in using algorithm 1
was in identifying the relevant data about the prevalence
of clean birth practices and CBK use. All participants
reported that the proportion of clean births in Pakistan
was very low. When asked to provide a figure, six of the
interview participants estimated that 30-40% of women
had access to clean birth practices. The FGD partici-
pants also came to a consensus on 30-40%, while the
remaining three interview participants suggested lower
estimates of between 10-15%. One participant noted that
clean birth practices were lower in rural areas and in
home deliveries in particular:
“. . .in home delivery only 10% deliveries will have
these cleans [the six cleans] 90% will not observe the
practices.” (P5)
Focus group participants reported that although
there was a problem with births attended by unskilled
Figure 4 Algorithm 3 – identifying whether there is a need for additional components.
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attendants, skilled attendants also had lapses in clean
birth practices:
“Even our Doctors don’t take care of hand washing. It’s
a very simple and economical method but it is not
taken care of.” (FG1)
Feedback on algorithm 1 confirmed a role for CBKs
beyond just providing commodities. Participants agreed
that CBKs could have an important role in raising
awareness among women, as well as birth attendants, of
the need for clean birth practices:
“It’s a chain of education . . ...When you are giving
something then you are also going to tell them what to
do with it and how to use it.” (P1)
However, participants had mixed views with regard to
whether CBKs could act as an incentive to facility birth.
One participant cited an example where a CBK, intro-
duced by a local non-government organisation (NGO),
acted as an incentive for women to go to a facility.
Others were less certain. One stated:
“I don’t think so. . . .. If the kit is there then at least the
kit will be utilized wherever she goes for delivery. But
the presence of kit only cannot be the incentive. Bigger
motivation is SBA [Skilled Birth Attendant].” (P5)
Most participants thought that CBKs would not act as
a disincentive for facility birth. However, one participant
expressed caution and suggested that the method of dis-
tribution would need to be tested:
“It can happen they [women] may say why go to
anyone if daia has this, let’s have delivery from her. If
this is looked at through a short study it will be
better.” (P1)
FGD participants felt that the distinction between ‘lack
of commodities’ and ‘lack of awareness’ could be clearer
in algorithm 1 and recommended a minor modification
so that both an individual option and a joint option were
available.
Algorithm 2
The issue of distribution, explored using algorithm 2,
proved challenging for participants. The policy makers
at the federal level expressed less certainty about the dis-
tribution and use of CBKs than policy makers and
implementers at provincial level or FGD participants.
Skilled birth attendants (SBAs) were identified to be
the main users or recipients of the CBKs. Pregnant
mothers were identified as users by some participants
and a few considered Dais or TBAs. FGD participants
noted that although there was a move to replace TBAs
with SBAs, if CBKs were made readily available to TBAs
then infection rates would be greatly reduced. Both
interview participants and FGD participants believed
that training or refresher training would be required for
the users of the CBKs.
Most of the participants were in favour of distributing
the CBK at household or community level. Various sug-
gestions included giving CBKs direct to women at regis-
tration, via antenatal clinics, health facilities, shops and
pharmacies, and through private doctors. However, some
participants noted that the approach should not be lim-
ited to one method:
“It should be a mixture where the facility is there or
not there, availability should be universal.” (P1)
“You cannot categorize any one [approach] it has to be
a multi-pronged approach.” (P4)
Although identifying who should distribute CBKs was
not easy, most participants felt that Lady Health Work-
ers (LHWs) would be the most appropriate group, since
they interfaced directly with the population at commu-
nity level. LHWs are female community health workers
who receive training, medical supplies and a small allow-
ance from a government health facility to which they are
attached [21]. LHWs provide essential primary health
services such as health education, antenatal and postna-
tal care, and family planning services. Both interview
participants and focus group participants felt that this
was the most appropriate method of CBK distribution
because LHWs covered a large amount of the popula-
tion. Comments included:
“their [LHWs] responsibility is to be present at the
time of birth.” (P1)
“Structure wise LHWs are strong and can be done
substantially through them.” (P4)
“There will be extra cost involved if it is other than
LHWs.”(P5)
There were no problems with the flow or wording of
algorithm 2. Participants found the tool useful in helping
to think about the best way to get CBKs to potential
users.
Algorithm 3
Discussion around algorithm 3 focused on the wish list
versus the realistic list:
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“the things related to common causes should be added,
otherwise it can be suggested to put a gynecologist also
in the kit, if possible!” (P9).
Other concerns related to the importance of planning
a programme of training to accompany any additions to
the kit. For example, a number of participants men-
tioned that misoprostol might be included in a CBK if
birth attendants received a programme of training first.
However, participants felt that the algorithm did draw
the decision maker’s attention to issues of practicality
and training.
Participants recognised that the decision support tool
could not be used in isolation and that other compo-
nents, such as training, would be important in helping
policy makers reach decisions about strategies for care
at birth. Some participants suggested that the data
needed for the algorithms (such as mortality rates, num-
ber of skilled birth attendants and costs) would need to
be collected in advance of the discussions: “This will
need a detailed review.”(P1). It was suggested that coun-
try specific data sources could be included in an appen-
dix to the tool.
The findings from the country level testing were pre-
sented and reviewed at a meeting of the BKWG. Minor
modifications were agreed to clarify algorithm 1 and the
guidance for algorithm 3, however the group decided
that country specific data sources could not be linked to
the tool since each country was likely to require a differ-
ent set of data. Instead it was agreed that a generic list
of resources would be added as an appendix to the tool.
Discussion
The test indicated that policy makers and programme
managers found the decision support tool useful in
stimulating discussion around the role of CBKs for
country level strategies for care at birth. Previous studies
have shown that CBKs (a collection of disposable com-
modities) are effective at promoting clean birth when
used as part of a strategy that includes education [8].
The tool helped policy makers to identify whether the
prevalence of clean birth practices was low and if so to
identify the reason for this (access to commodities,
awareness and/or knowledge). Using the second algo-
rithm participants were able to conceptualise how CBKs
could be used to as a means of distributing commodities
in areas where supply chains are erratic. There is evi-
dence that the performance of health systems in low in-
come countries may be marred by several factors
including lack of adequate resources, infrastructure, co-
ordination and management [22]. However, a lack of
supplies and commodities is central to the ineffective
utilisation of health services and deters clients, mainly
women and children, from making contact with public
health facilities or staff. Consequently those who can af-
ford it resort to private health systems to provide the
necessary medical commodities, but such services are
unregulated, over-priced [23] and can pose serious
health challenges [24].
Although extra resources are required to meet medical
commodity needs, effective supply chain management is
a necessary prerequisite and requires strengthening and
innovative approaches to address the gap [25]. CBKs are
one potential strategy to facilitate the packaging of med-
ical supplies together thereby ensuring a clean, and
hence safe, delivery process. Such commodities might be
included within the CBK, as in the recent study of chlor-
hexadine [26], or be ‘bundled’ with a CBK for distribu-
tion. In developing the decision support tool we
acknowledged the fact that the distribution mechanism
and content should be congruent with regional varia-
tions in community needs and health systems. Hence,
the tool is especially useful for decentralised health sys-
tems where some key decision making about the nature
and content of the health service takes place locally.
It is important to highlight that a decision support
tool, aimed at increasing access to commodities, cannot
on its own be sufficiently effective in making positive
changes in maternal and newborn outcomes in low in-
come countries [27,28]. Such tools need to be used
alongside a regular supply chain, community mobilisa-
tion and health staff training. Participants in our test
reported that the decision support tool enabled them to
discuss how CBKs could be used to raise awareness of
clean birth practices through existing health systems,
and how a CBK could be modified to incorporate educa-
tional interventions to facilitate these practices. How-
ever, they recognised that the tool was only one
component in the strategy to improve care at birth.
Although the test was successful, the policy makers
and programme managers recognised the need for coun-
try level data to support these discussions. Participants
acknowledged that they often did not have data to sup-
port their estimates. We did not attempt to verify the
estimates given or to measure the prevalence of clean
birth practices in country. Instead our aim was to guide
the policy maker or programme manager through a
series of steps, which could require the use of existing
data, in order to make decisions about whether to use
CBKs. Further research is needed to explore how na-
tional level evidence synthesis can be incorporated into
the process and how the tool can be adapted to meet
district needs.
Conclusion
We have developed a decision support tool for policy
makers and programme managers who are considering
the potential role of CBKs in their strategy for care at
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birth. Testing of the tool in Pakistan suggests that the
tool facilitates discussion and aids decision making.
However, further testing in other countries is needed to
determine whether these results can be replicated and to
identify how the tool can be adapted to meet country
specific needs.
Endnotes
aAn untrained traditional birth attendant.
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